T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $283K | ﹤0.01% |
+3,000
| New | +$279K |
|
2452
Tactile Systems Technology
TCMD
$537M
| $283K | ﹤0.01% |
17,371
+1,159
| +7% | +$17.5K |
|
2453
Bally's
BALY
$660M
| $281K | ﹤0.01% |
20,132
+1,394
| +7% | +$16.2K |
|
2454
BioLife Solutions
BLFS
$1.72B
| $281K | ﹤0.01% |
15,129
+1,374
| +10% | +$24K |
|
2455
Royal Bank of Canada
RY
$299B
| $280K | ﹤0.01% |
2,770
| – | – |
|
|
MRNS
2456
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $280K | ﹤0.01% |
30,929
+2,624
| +9% | +$25.5K |
|
2457
Douglas Elliman
DOUG
$183M
| $279K | ﹤0.01% |
176,451
+5,671
| +3% | +$11.6K |
|
2458
LSB Industries
LXU
$711M
| $278K | ﹤0.01% |
31,581
+1,837
| +6% | +$14.5K |
|
2459
Peapack-Gladstone Financial
PGC
$822M
| $278K | ﹤0.01% |
11,423
+628
| +6% | +$16.1K |
|
2460
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $278K | ﹤0.01% |
+5,535
| New | +$264K |
|
|
UDMY
2461
DELISTED
Udemy
UDMY
| $278K | ﹤0.01% |
25,265
-291,675
| -92% | -$3.62M |
|
2462
Xeris Biopharma Holdings
XERS
$1.52B
| $278K | ﹤0.01% |
125,635
+10,632
| +9% | +$27.5K |
|
|
KYNB
2463
Kyntra Bio
KYNB
$28.5M
| $276K | ﹤0.01% |
4,690
+234
| +5% | +$10.1K |
|
|
KLG
2464
DELISTED
WK Kellogg Co
KLG
| $276K | ﹤0.01% |
14,638
+2,009
| +16% | +$29.2K |
|
2465
Beyond Meat
BYND
$210M
| $275K | ﹤0.01% |
33,104
+2,790
| +9% | +$21.5K |
|
2466
Schneider National
SNDR
$6.37B
| $275K | ﹤0.01% |
12,109
+1,699
| +16% | +$40.3K |
|
2467
Atea Pharmaceuticals
AVIR
$406M
| $272K | ﹤0.01% |
67,137
+11,968
| +22% | +$46.8K |
|
2468
Designer Brands
DBI
$312M
| $271K | ﹤0.01% |
24,776
| – | – |
|
2469
Taboola.com
TBLA
$1.06B
| $271K | ﹤0.01% |
+61,024
| New | +$272K |
|
|
BAND
2470
Bandwidth Inc
BAND
$1.74B
| $269K | ﹤0.01% |
14,713
+1,334
| +10% | +$21K |
|
2471
MINISO
MNSO
$3.53B
| $269K | ﹤0.01% |
13,100
| – | – |
|
2472
iShares National Muni Bond ETF
MUB
$45.9B
| – | – |
0
| – | – |
|
2473
Novavax
NVAX
$1.34B
| $269K | ﹤0.01% |
56,065
+8,128
| +17% | +$37.7K |
|
2474
QuinStreet
QNST
$1.19B
| $269K | ﹤0.01% |
15,188
+1,694
| +13% | +$24.1K |
|
2475
Birkenstock
BIRK
$7.54B
| $268K | ﹤0.01% |
5,668
-80
| -1% | -$3.82K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.